Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to Monotherapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with schizophrenia and schizoaffective disorder according to International Classification of Diseases (ICD-10);~* age 18-65;~* Positive and Negative Symptom Scale Total-Score ≥ 70 and two items of the positive symptom subscale ≥4.~* voluntary treatment after written informed consent~* legal capacity~* exclusion of pregnancy by laboratory test (Beta HCG)~Exclusion Criteria:~* participation in other interventional studies with drugs or medical devices~* first episode patients~* physical disease that might have effects on the conduct or evaluation of the trial~* contraindications to medication according to experts information~* oversensitivity to active substance or other component of the drugs used~* known clozapine resistance~* suicidal ideation~* pregnancy or lactation~* which of pregnancy or absence save contraception~* dependency to sponsor or investigator~* institutionalization through judicial or regulatory order~* oversensitivity to placebo (mannite/aerosil)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Olanzapine or Placebo (Type: ACTIVE_COMPARATOR): None
- Amisulpride or Placebo (Type: ACTIVE_COMPARATOR): None
- Olanzapine and Amisulpride (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).